This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA economists summarize the key points discussed in MOFCOM’s announcement regarding the economic analyses it considered in evaluating Thermo Fisher Scientific’s $13.5 billion acquisition of Life Technologies Corp.
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...
We are pleased to present the latest edition of CRA’s IP Literature Watch. This issue contains pieces on antitrust & IP, licensing, litigation, innovation, law...
CRA is a proud sponsor of the event bringing together local and international private practitioners, corporate counsel, and government enforcers, to explore...
CRA is a proud sponsor of the event featuring four panels, two focused on inclusion and careers, and two focused on antitrust law. Inclusion will be the...
